Carole Guillonneau

Carole Guillonneau is an accomplished researcher and co-founder of AbolerIS Pharma, serving as Head of Research since November 2019. Carole is also the Director of the FOCIS Center of Excellence at Nantes University, a role held since June 2022. In addition, Carole has been a Director of Research at the CNRS since October 2017, leading teams focused on cell and gene engineering in immunology and regenerative medicine. Prior experience includes roles as Chargé de Recherche at CNRS from 2009 to 2017 and a post-doctorate at Melbourne University. Carole holds a PhD in Immunology from Université Paris Cité and has completed the Entrepreneurs in Clinical Academia program at INSEAD. Additionally, Carole serves as an Associate Editor for the journal Transplantation.